0001209191-23-006398.txt : 20230202
0001209191-23-006398.hdr.sgml : 20230202
20230202183236
ACCESSION NUMBER: 0001209191-23-006398
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230201
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Monohon Ted
CENTRAL INDEX KEY: 0001606905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 23582844
MAIL ADDRESS:
STREET 1: C/O FANTEX, INC.
STREET 2: 330 TOWNSEND ST., SUITE 234
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quince Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 901024039
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Cortexyme, Inc.
DATE OF NAME CHANGE: 20160104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-01
0
0001662774
Quince Therapeutics, Inc.
QNCX
0001606905
Monohon Ted
C/O QUINCE THERAPEUTICS, INC.
601 GATEWAY BLVD., SUITE 1250
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Accounting Officer & VP
Employee Stock Option (right to buy)
0.94
2023-02-01
4
A
0
110000
0.00
A
2033-01-31
Common Stock
110000
110000
D
The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.
/s/ Ted Monohon
2023-02-02